The novel therapy of the medication represents a exciting development in the care of type 2 diabetes. Distinct from existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide573977.blogminds.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-38892084